Arbutus Biopharma 10Q 2016 Q1 Quarterly report | ABUS Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: Anlylam, area, aspect, attention, behalf, bloodstream, broaden, cancellation, cautionary, cellular, Center, chemically, circulation, clarification, coding, complement, complex, complexity, contrast, conversion, costly, coupon, credible, crippling, crucial, customer, denominated, disposition, editing, eleven, exposed, GalNAc, handling, hypothetical, immaterial, implementation, inability, inside, instability, intervene, intravenously, intrinsic, iral, lease, lifecycle, mediate, methodology, patisisiran, polymerase, post, qualified, receptor, reclassification, region, restated, Ribonuclease, RNaseH, SAD, Saint, smaller, split, stay, strong, suited, summary, transition, travel, undergoing, unrecognized, version, volunteer

Removed: AB, absence, absorb, ACC, accrual, achievable, acid, acquirer, adaptive, adrenal, Adrenocortical, advancement, advancing, advantage, African, aggressive, agonism, ahead, al, alcohol, allocated, AlocrestTM, amendment, American, amortization, amortized, Amyloidotic, animal, antagonism, APOLLO, approach, architecture, arise, arm, arrest, assay, assist, assumption, ATTR, attractive, attribution, authorization, awarded, begin, biomarker, biomedical, BrakivaTM, Branch, broader, broadly, budget, budgeted, carcinoma, care, Carolina, cast, CgA, Charleston, chemistry, closing, cohort, combined, commitment, committed, compensate, compete, composition, concurrent, conference, confirmed, consistent, consortium, consummated, consummation, contingency, continuing, conventional, converting, criteria, curing, database, deadly, death, decade, deductible, deducting, delisted, delisting, delivered, demonstrated, demonstrating, designation, die, dilutive, discretion, division, documented, element, elevated, Emerging, employ, encouraging, engine, enroll, enrolling, entecavir, entering, EP, escalation, establishing, evaluable, evidence, evolve, exchanged, exhibit, expansion, expedited, experience, experienced, expertise, expiration, expressed, extend, extending, extension, fall, Familial, FAP, Fast, fever, final, finalized, fluctuate, Food, forecasting, forma, formulated, Forty, Foundation, fourth, Galveston, gastrointestinal, genetic, gland, Globocan, goal, goodwill, halting, hearing, heavily, hemorrhagic, hepatocellular, hoped, hosted, humanized, identifiable, identification, impacted, impacting, improved, inception, incidence, indefinite, index, indirect, industry, ineffective, inflammation, informational, integrate, integrated, intention, interference, interfering, internally, intervention, involving, IP, irregular, ISARIC, issuable, Japan, joined, journal, lab, label, lack, lamivudine, led, Leone, lethal, leveraging, list, literature, local, log, making, Makona, Marburg, marqibo®, maximizing, mechanism, Merck, messenger, metabolic, metastatic, minimum, mode, modification, modified, moved, moving, MTD, NASDAQ, National, natural, neoplasm, neuroendocrine, neuropathy, Nexavar, NIH, nil, nonhuman, North, notified, NUC, nucleic, nucleotide, offered, offset, OLE, oncology, open, opportunity, ordering, Oxford, paper, partially, partnering, pDC, people, percent, permanent, Polyneuropathy, poor, poorer, population, positive, potency, power, predecessor, predetermined, preliminary, prevalence, privately, pro, profile, proliferation, protection, protocol, published, put, quarter, quickly, randomized, ranged, rapid, RAPIDE, rational, reach, realization, realizing, recent, RECIST, recoverable, refer, refined, reflected, reliably, rely, repeat, represent, reserved, Respiratory, rest, retained, robust, rolling, sale, San, scarring, science, SEER, separately, shared, Sierra, silence, siRNA, size, Society, solid, sorafenib, South, specifically, spent, step, steroid, subsequently, subset, suggest, surgical, survival, surviving, suspected, sustained, symbol, symposium, systemic, tangible, targeted, team, Tekmira, tenofovir, terminate, test, testing, thereof, TKM, Tokyo, Toronto, Transformational, translate, transthyretin, treasury, treating, Tropical, Trust, TSX, TTR, Tuesday, tumor, twelve, UK, uncertain, underwriting, undisclosed, unfunded, unique, unnecessary, unrecovered, updated, USA, UTMB, validate, validated, validation, vesting, viable, voluntarily, voluntary, voting, Voucher, week, weekly, Wellcome, wholly, wide, world, worth, Yao



	/s/ Bruce Cousins
	Name: Bruce Cousins
	Title: Executive Vice President, Finance and
	Chief Financial Officer


1.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


2.	The information contained in the Report fairly represents, in all material respects, the financial condition and results of the operations of the Company.

Arbutus Biopharma (ABUS) 10-Q2016 Q1 Quarterly report

Content analysis